ADMA Biologics Ownership | Who Owns ADMA Biologics?
ADMA Biologics Ownership Summary
ADMA Biologics is owned by 84.84% institutional investors, 2.57% insiders, and 12.59% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 15.10% of ADMA shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.98% of its assets in ADMA Biologics shares.
ADMA Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | ADMA Biologics | 84.84% | 2.57% | 12.59% |
Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Blackrock funding, inc. /de | 36.47M | 15.10% | $664.18M |
Blackrock | 18.64M | 8.15% | $208.45M |
Vanguard group | 18.20M | 7.76% | $312.11M |
State street | 14.87M | 6.34% | $255.03M |
Invesco | 11.30M | 4.82% | $193.73M |
Geode capital management | 5.43M | 2.32% | $93.19M |
Morgan stanley | 4.60M | 2.01% | $51.41M |
Dimensional fund advisors lp | 4.67M | 1.99% | $80.07M |
Nuveen asset management | 4.55M | 1.94% | $78.07M |
American century companies | 4.61M | 1.91% | $83.97M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Stonepine capital management | 750.00K | 13.40% | $13.66M |
Awm investment company | 2.20M | 4.49% | $40.06M |
Ophir asset management pty | 1.22M | 3.61% | $22.70M |
Palisades investment partners | 398.65K | 3.17% | $7.26M |
Oberweis asset management inc/ | 3.14M | 2.48% | $57.10M |
First light asset management | 952.10K | 2.25% | $17.34M |
First turn management | 684.23K | 2.10% | $11.73M |
Lisanti capital growth | 275.95K | 1.39% | $5.03M |
Marathon capital management | 283.69K | 1.32% | $5.17M |
Aubrey capital management | 189.80K | 1.25% | $3.45M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Allspring global investments | 2.84M | 0.08% | 2.61M |
State street | 14.87M | 0.01% | 1.87M |
T. rowe price investment management | 1.67M | 0.02% | 1.67M |
Fmr | 3.20M | 0.00% | 1.25M |
First light asset management | 952.10K | 2.25% | 952.10K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
D. e. shaw | 3.07M | 0.04% | -2.20M |
Bank of montreal /can/ | 26.56K | 0.00% | -2.06M |
Nuveen asset management | 4.55M | 0.02% | -2.03M |
Velan capital investment management lp | - | - | -1.53M |
Two sigma advisers, lp | 2.95M | 0.12% | -1.50M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
T. rowe price investment management | 1.67M | 0.02% | 1.67M | $30.40M |
First light asset management | 952.10K | 2.25% | 952.10K | $17.34M |
Abrdn | 531.78K | 0.02% | 531.78K | $9.68M |
Renaissance group | 343.57K | 0.24% | 343.57K | $6.26M |
Osterweis capital management | 296.50K | 0.26% | 296.50K | $5.40M |
Sold Out
Holder | Change |
---|---|
Mendota financial group | -4.00 |
Corecap advisors | -7.00 |
Global financial private client | -24.00 |
Aquatic capital management | -27.00 |
Stephens consulting | -60.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2025 | 376 | 4.16% | 204,872,171 | 0.17% | 84 | 1.15% | 230 | 18.56% | 107 | -6.96% |
Mar 31, 2025 | 357 | 8.51% | 204,309,752 | 0.18% | 85 | 1.14% | 192 | -4.00% | 113 | 9.71% |
Dec 31, 2024 | 321 | 3.55% | 200,305,365 | -3.74% | 85 | 1.09% | 196 | 1.55% | 99 | 2.06% |
Sep 30, 2024 | 309 | 20.23% | 208,056,497 | 15.00% | 88 | 1.42% | 193 | 29.53% | 96 | 18.52% |
Jun 30, 2024 | 255 | 17.51% | 180,834,881 | 3.64% | 79 | 1.33% | 149 | 7.97% | 80 | 53.85% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
iShares Core S&P Small-Cap ETF | 14.26M | 5.98% | 2.05K |
Vanguard US Total Market Shares ETF | 7.15M | 3.01% | 281.42K |
Vanguard Total Stock Mkt Idx Inv | 7.17M | 3.01% | -150.89K |
iShares Russell 2000 ETF | 5.46M | 2.29% | -103.74K |
SPDR® S&P Biotech ETF | 3.23M | 1.35% | 79.58K |
Xtrackers MSCI World Swap ETF 1C | 2.97M | 1.24% | - |
CREF Stock R1 | 2.80M | 1.20% | -102.61K |
Vanguard Small Cap Index | 2.75M | 1.15% | -18.30K |
American Century Small Cap Growth Inv | 2.62M | 1.10% | 447.92K |
American Century U.S. Small Cap Growth | 2.62M | 1.10% | 447.92K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Sep 15, 2025 | Grossman Adam S | President and CEO | Sell | $241.95K |
Sep 15, 2025 | Grossman Adam S | President and CEO | Sell | $96.78K |
Aug 15, 2025 | Grossman Adam S | President and CEO | Sell | $101.28K |
Aug 15, 2025 | Grossman Adam S | President and CEO | Sell | $253.20K |
Jul 15, 2025 | Grossman Adam S | President and CEO | Sell | $111.96K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q3 | - | 6 |
2025 Q2 | - | 13 |
2025 Q1 | - | 2 |
2024 Q4 | - | 2 |
2024 Q3 | - | 6 |
ADMA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools